Meningitis: Vaccination

Treasury written question – answered at on 16 July 2014.

Alert me about debates like this

Photo of Tony Cunningham Tony Cunningham Labour, Workington

To ask the Chancellor of the Exchequer when his Department received the business case for the meningococcal B vaccine; and when he expects to make a decision whether or not to approve the business case.

Photo of Danny Alexander Danny Alexander The Chief Secretary to the Treasury

On 21 March 2014, the Joint Committee on Vaccination and Immunisation (JCVI) recommended that there should be a national Meningococcal B immunisation programme for infants, if the vaccine, Bexsero ®, could be purchased at a cost-effective price. The Treasury is working closely with the Department of Health on this business case. The Government would like to secure the vaccine from the supplier at the cost-effective price recommended by the JCVI.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.